Evidence map›Paper›PMID 36985657›Full record

ArticleMolecules (Basel, Switzerland)2023

Chemical Constituents of

Zhen-Zhen Liu, Jun-Cheng Ma, Peng Deng, Fu-Cai Ren, Ning Li

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  4. Anti-Inflammatory Effect of Xanthones fromMolecules (Basel, Switzerland) · 2024
    Article
  5. Astragalin fromAntioxidants (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Exploring Information Exchange betweenPlants (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhen-Zhen LiuInflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
Jun-Cheng MaInflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
Peng DengInflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
Fu-Cai RenInflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei 230032, China.ORCID 0000-0002-8685-9283
Ning LiInflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei 230032, China.

Funding

Major Project of Science and Technology of Anhui Province 202203a07020014Scientific Research Platform Improvement Project of Anhui Medical University 2022xkjT045the National Science Foundation of China 32270424
6 · The paper itself

Abstract

Three novel compounds (

Indexed as

Antineoplastic AgentsAntioxidantsAnimalsAnti-Inflammatory AgentsCell LineHumansMiceMolecular StructureRAW 264.7 CellsAnti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsanti-inflammatory activityantioxidantchemical constituentscytotoxicityThesium chinense Turcz

Identifiers

PMID36985657
PMCPMC10054634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.